Before the Covid-19 pandemic, health care venture funding and
deal activity were approaching record highs annually. As a result,
hospitals and health systems faced greater competition from
start-ups each year. Now, as consumer behaviors and economic
conditions change, start-ups are experiencing two diverging
future outlooks. In this publication, we will explore these two
outlooks—one for companies expected to thrive, and another for
organizations that may falter—in light of the novel coronavirus.
Read on for our full take or download a PDF version below. For additional Advisory Board takes on the long-term implications of Covid-19, click here.
Next, Check Out
Innovative players shaping care delivery competition